chlorpropamide has been researched along with Parkinsonian Disorders in 2 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JD | 1 |
| Stone, DB | 1 |
| BARRINGTON, PC | 1 |
2 other studies available for chlorpropamide and Parkinsonian Disorders
| Article | Year |
|---|---|
TOLBUTAMIDE-INDUCED HYPOGLYCEMIA.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Chlorpropamide; Diabetes Mellitus; Drug Therapy; Female; | 1964 |
CHLORPROPAMIDE IN PARKINSON'S DISEASE.
Topics: Biomedical Research; Chlorpropamide; Drug Therapy; Humans; Parkinson Disease; Parkinsonian Disorders | 1964 |